MyFinsight
Home
Blog
About
Maturities of marketable
securities
$4,000K
(-81.82%↓ Y/Y)
Employee stock purchase
plan ('espp')...
$437K
(-20.26%↓ Y/Y)
Net cash provided by
investing activities
$3,889K
(-78.13%↓ Y/Y)
Net cash provided by
financing activities
$437K
(-52.60%↓ Y/Y)
Canceled cashflow
$111K
Net decrease in cash
and cash...
$830K
(145.26%↑ Y/Y)
Canceled cashflow
$3,496K
Purchase of plant and
equipment
$108K
(-85.50%↓ Y/Y)
Patent filing fees
$3K
(-76.92%↓ Y/Y)
Stock-based compensation
$1,988K
(-62.97%↓ Y/Y)
Accrued wages and fringe
benefits
$951K
(137.89%↑ Y/Y)
Other current
liabilities
$911K
(326.05%↑ Y/Y)
Inventory
-$765K
(-194.44%↓ Y/Y)
Depreciation and
amortization
$605K
(-43.62%↓ Y/Y)
Non-cash lease expense
$240K
(-45.21%↓ Y/Y)
Current non-qualified
deferred compensation...
$234K
(113.69%↑ Y/Y)
Loss on fixed asset
disposal
-$188K
(45.19%↑ Y/Y)
Corporate-owned life insurance
('coli') asset
-$187K
(53.94%↑ Y/Y)
Non-cash changes in the
fair value of nqdc...
-$135K
(-112.31%↓ Y/Y)
Excess and obsolete
inventory related charges
-$65K
(88.03%↑ Y/Y)
Provision for credit
losses
$14K
(333.33%↑ Y/Y)
Remeasurement and foreign
currency transaction...
-$10K
Trade and other
receivables
$5K
(-99.64%↓ Y/Y)
Net cash used in
operating activities
-$3,496K
(82.98%↑ Y/Y)
Canceled cashflow
$6,298K
Net loss
-$7,663K
(67.77%↑ Y/Y)
Accounts payable and
accrued expenses
-$762K
(-184.57%↓ Y/Y)
Prepaids and other
current assets
$721K
(292.27%↑ Y/Y)
Change in fair value of
loan facility
-$211K
(-36.13%↓ Y/Y)
Operating lease liability
-$159K
(65.95%↑ Y/Y)
Non-qualified deferred
compensation plan liability
-$142K
(-108.84%↓ Y/Y)
Other long-term
assets
$60K
(-79.59%↓ Y/Y)
Amortization of premium of
marketable securities
-$43K
(77.72%↑ Y/Y)
Change in fair value of
warrant liabilities
-$24K
(98.43%↑ Y/Y)
Contract liabilities
-$9K
(47.06%↑ Y/Y)
Other income, net
$688K
(-59.36%↓ Y/Y)
Total revenues
$21,702K
(-41.24%↓ Y/Y)
Loss before income
taxes
-$7,630K
(67.90%↑ Y/Y)
Income tax expense
$33K
(175.00%↑ Y/Y)
Canceled cashflow
$688K
Gross profit
$17,767K
(-41.99%↓ Y/Y)
Canceled cashflow
$3,935K
Operating loss
-$6,855K
(70.16%↑ Y/Y)
Interest expense
$1,463K
(-41.13%↓ Y/Y)
Canceled cashflow
$17,767K
Purchases of inventory
$3,483K
(-39.69%↓ Y/Y)
Other cost of sales
$452K
(-14.39%↓ Y/Y)
Total operating
expenses
$24,622K
(-54.07%↓ Y/Y)
Sales and marketing
$13,573K
(-53.43%↓ Y/Y)
General and
administrative
$5,971K
(-54.27%↓ Y/Y)
Research and development
$5,078K
(-55.46%↓ Y/Y)
Back
Back
Cash Flow
AVITA Medical, Inc. (RCEL)
AVITA Medical, Inc. (RCEL)
source: myfinsight.com